How many clinical trials are tracked for Blepharitis?

13 trials are tracked, 3 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Blepharitis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Blepharitis

13 trials tracked for Blepharitis: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 168 citations.

13Trials tracked

6Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 4 2 Phase 3 4 Phase 2 6 Other / NA 1

Phase 4 Lipids of the Human Tear Film and Their Effect on Tear Stability Completed · 168 cited
Phase 3 Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Completed · 48 cited
Phase 3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Completed · 45 cited
Phase 4 Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Completed
Phase 3 Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Completed
Phase 3 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Completed

Show 7 more trials

Phase 2 Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Completed
Phase 2 Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Completed
Phase 2 Treatment of Patients With Blepharitis and Facial Rosacea Completed
Phase 2 Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis Completed
Phase 2 Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis Completed
Phase 2 Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD Completed
N/A Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.